Citations

Mayo Clinic

Showing 10 of 108585 citations.

Partially Observable Markov Decision Process Model for Dynamic Human Activity Recognition Using Radio Frequency Signals
Wang, Feifan , Jones, Derick D. , Walker, Laura M. , Salehinejad, Hojjat , Walker, Laura, Borah, Bijan J. , Wang, Feifan

2023 IEEE 19th International Conference on Automation Science and Engineering (CASE) | September 28, 2023 | Volume: No volume available | Issue: No issue available | Pages: 1-6

10.1109/case56687.2023.10260550 Get It

Technician Scheduling and Staffing for Medical Procedures in Heart Rhythm Services
Wang, Feifan , Huang, Yu-Li , Graff, Susan, Peterson, Joshua, Wang, Feifan

2023 IEEE 19th International Conference on Automation Science and Engineering (CASE) | September 28, 2023 | Volume: No volume available | Issue: No issue available | Pages: 1-6

10.1109/case56687.2023.10260461 Get It

Endotheliitis and cytokine storm as a mechanism of clot formation in COVID-19 ischemic stroke patients: A histopathologic study of retrieved clots
Brinjikji, Waleed , Kallmes, David F. , Humphries, William, Zaidat, Osama O. , Jones, Jesse , Siddiqui, Adnan H. , Douglas, Andrew , Rossi, Rosanna , Rentzos, Alexander, Ceder, Erik , Carlqvist, Jeanette , Dunker, Dennis, Doyle, Karen , Jones, Jesse , Rossi, Rosanna , Doyle, Karen M , Siddiqui, Adnan H , Virmani, Renu , De Meyer, Simon F , Yoo, Albert J. , Teleb, Mohamed , Andersson, Tommy , Nogueira, Raul G. , Gil, Sara Molina, Rentzos, Alexander, Jood, Katarina , Tatlisumak, Turgut

Interventional Neuroradiology | September 28, 2023 | Volume: 31 | Issue: 5 | Pages: 660-665

10.1177/15910199231185804 | PMID 37769315 Get It

Background Studies during the COVID-19 pandemic have demonstrated an association between COVID-19 virus infection and the development of acute ischemic stroke, particularly large vessel occlusion (LVO). Studying the characteristics and immunohistochemistry of retrieved stroke emboli during mechanical thrombectomy for LVO may offer insights into the pathogenesis of LVO in COVID-19 patients. We examined retrieved COVID-19 emboli from the STRIP, EXCELLENT, and RESTORE registries and compared their characteristics to a control group. Methods We identified COVID-positive LVO patients from the STRIP, RESTORE, and EXCELLENT studies who underwent mechanical thrombectomy. These patients were matched to a control group controlling for stroke etiology based on Trial of Org 10172 in Acute Stroke Treatment criteria. All clots were stained with Martius Scarlet Blue (MSB) along with immunohistochemistry for interleukin-6 (IL-6), C-reactive protein (CRP), von Willebrand factor (vWF), CD66b, fibrinogen, and citrullinated Histone H3. Clot composition was compared between groups. Results Nineteen COVID-19-positive patients and 38 controls were included. COVID-19-positive patients had a significantly higher percentage of CRP and vWF. There was no difference in IL-6, fibrin, CD66b, or citrullinated Histone H3 between groups. Based on MSB staining, there was no statistically significant difference regarding the percentage of red blood cells, white blood cells, fibrin, and platelets. Conclusions Our study found higher concentrations of CRP and vWF in retrieved clots of COVID-19-positive stroke patients compared to COVID-19-negative controls. These findings support the potential role of systemic inflammation as indicated by elevated CRP and endothelial injury as indicated by elevated vWF as precipitating factors in thrombus development in these patients.
Discrete class I molecules on brain endothelium differentially regulate neuropathology in experimental cerebral malaria
Fain, Cori E. , Zheng, Jiaying , Jin, Fang, Ayasoufi, Katayoun , Wu, Yue , Lilley, Meredith T. , Dropik, Abigail R. , Rodriguez, Robert C , Aibaidula, Abudumijiti, Tritz, Zachariah P. , Bouchal, Samantha M. , Pewe, Lecia L. , Urban, Stina L. , Chen, Yin, Chang, Su-Youne , Hansen, Michael J. , Kachergus, Jennifer M., Shi, Ji , Thompson, E. Aubrey , Jensen, Hadley E, Harty, John T. , Wu, Long‐Jun , Johnson, Aaron J. , Wolf, Delaney M. , Tritz, Zachariah P , Parney, Ian F , Wu, Long-Jun , Johnson, Aaron J. , Ayasoufi, Katayoun , Lilley, Meredith T , Dropik, Abigail R , Zheng, Jiaying , Bouchal, Samantha M , Parney, Ian F. , Sun, Jie

Brain | September 28, 2023 | Volume: 147 | Issue: 2 | Pages: 566-589

10.1093/brain/awad319 | PMID 37776513 Get It

Abstract Cerebral malaria is the deadliest complication that can arise from Plasmodium infection. CD8 T-cell engagement of brain vasculature is a putative mechanism of neuropathology in cerebral malaria. To define contributions of brain endothelial cell major histocompatibility complex (MHC) class I antigen-presentation to CD8 T cells in establishing cerebral malaria pathology, we developed novel H-2Kb LoxP and H-2Db LoxP mice crossed with Cdh5-Cre mice to achieve targeted deletion of discrete class I molecules, specifically from brain endothelium. This strategy allowed us to avoid off-target effects on iron homeostasis and class I-like molecules, which are known to perturb Plasmodium infection. This is the first endothelial-specific ablation of individual class-I molecules enabling us to interrogate these molecular interactions. In these studies, we interrogated human and mouse transcriptomics data to compare antigen presentation capacity during cerebral malaria. Using the Plasmodium berghei ANKA model of experimental cerebral malaria (ECM), we observed that H-2Kb and H-2Db class I molecules regulate distinct patterns of disease onset, CD8 T-cell infiltration, targeted cell death and regional blood–brain barrier disruption. Strikingly, ablation of either molecule from brain endothelial cells resulted in reduced CD8 T-cell activation, attenuated T-cell interaction with brain vasculature, lessened targeted cell death, preserved blood–brain barrier integrity and prevention of ECM and the death of the animal. We were able to show that these events were brain-specific through the use of parabiosis and created the novel technique of dual small animal MRI to simultaneously scan conjoined parabionts during infection. These data demonstrate that interactions of CD8 T cells with discrete MHC class I molecules on brain endothelium differentially regulate development of ECM neuropathology. Therefore, targeting MHC class I interactions therapeutically may hold potential for treatment of cases of severe malaria.
Imaging Characteristics of and Multidisciplinary Management Considerations for Atypical Ductal Hyperplasia and Flat Epithelial Atypia: Review of Current Literature
Harper, Laura K , Carnahan, Molly B. , Bhatt, Asha A. , Simmons, Curtis , Patel, Bhavika , Downs, Erinn , Pockaj, Barbara A. , Yancey, Kristina , Eversman, Sarah , Sharpe, Richard E. , Simmons, Curtis L , Patel, Bhavika K , Eversman, Sarah E, Harrison, Molly

RadioGraphics | September 28, 2023 | Volume: 43 | Issue: 10 | Pages: No page available

10.1148/rg.230016 | PMID 37768862 Get It

Selective Deep Lobe Parotidectomy vs Total Parotidectomy for Patients With Benign Deep Lobe Parotid Tumors
Wallerius, Katherine P. , Xie, Katherine , Lu, Lauren , Lohse, Christine M. , Abel, Kathryn M. Van , Moore, Eric J. , Xie, Katherine Z , Lu, Lauren Y, Van Abel, Kathryn M , Yin, Linda X. , Price, Daniel L.

JAMA Otolaryngology–Head & Neck Surgery | September 28, 2023 | Volume: 149 | Issue: 11 | Pages: 1003

10.1001/jamaoto.2023.2981 | PMID 37768672 Get It

ImportanceLimited literature exists on surgical outcomes after selective deep lobe parotidectomy (SDLP) with preservation of superficial lobe for patients with benign deep lobe tumors.ObjectiveTo compare the following factors for SDLP vs total parotidectomy for patients with benign tumors in the deep lobe: postoperative complications, including facial nerve paresis or paralysis, Frey syndrome, first bite syndrome, cosmetic defect, sialocele formation, and wound infection; and tumor control and recurrence.Design, Setting, and ParticipantsThis case series included 273 adults who underwent SDLP (n = 177) or total parotidectomy (n = 96) at a single tertiary care institution for benign parotid tumors located in the deep lobe or deep lobe and parapharynx from January 1, 2000, to December 31, 2020.ExposureSelective deep lobe parotidectomy vs total parotidectomy.Main Outcomes and MeasuresIncidence of postoperative complications and tumor recurrence.ResultsAmong 273 patients (SDLP, 177 [65%]; 122 women [69%]; median age at surgery, 58 years [IQR, 46-67 years]; total parotidectomy, 96 [35%]; 57 women [59%]; median age at surgery, 59 years [IQR, 40-68 years]), the most common tumor was pleomorphic adenoma (SDLP, 128 of 177 [72%]; total parotidectomy, 62 of 96 [65%]). An abdominal dermal fat graft was less commonly performed for patients who underwent SDLP than those who underwent total parotidectomy (2 of 177 [1%] vs 20 of 96 [21%]; difference, −20% [95% CI, −28% to −11%]). The rate of great auricular nerve preservation was higher in the SDLP group than in the total parotidectomy group (84 of 102 [82%] vs 20 of 34 [59%]; difference, 24% [95% CI, 5%-42%]). No meaningful difference in length of hospital stay was found. The percentage of patients with House-Brackmann grade I immediately after surgery was 48% (85 of 177) in the SDLP group and 21% (20 of 96) in the total parotidectomy group (difference, 28% [95% CI, 16%-40%]). There were no clinically meaningful differences in rates of hematoma, sialocele, seroma, ear numbness, wound infection, or unplanned return to emergency department or operating room. The SDLP group reported a lower rate of Frey syndrome than the total parotidectomy group (1 of 137 [1%] vs 12 of 78 [15%]; difference, −15% [95% CI, −23% to −7%]), as well as a lower rate of facial contour defect (28 of 162 [17%] vs 25 of 84 [30%]; difference, −13% [95% CI, −24% to −1%]) and a higher rate of first bite syndrome (34 of 148 [23%] vs 7 of 78 [9%]; difference, 14% [95% CI, 5%-23%]). The percentage of patients with House-Brackmann grade I at their first follow-up visit was 67% (118 of 177) in the SDLP group compared with 49% (47 of 96) in the total parotidectomy group (difference, 17% [95% CI, 4%-30%]). There was no clinically meaningful difference in House-Brackmann grade after 1 year.Conclusions and RelevanceFindings of this case series study suggest that SDLP can be considered an effective and even superior technique for management of benign tumors in the deep parotid lobe. Advantages associated with SDLP include reduction in need for reconstruction for facial contour defect and reduction in complications, such as immediate facial nerve weakness and Frey syndrome. The incidence of first bite syndrome was higher in the SDLP group. Tumor control was not compromised by SLDP.
Geriatric Assessments in Older Adults With Cancer
Diaz, Fernando Cristobal, Velázquez, Ana I. , Tsang, Mazie

JAMA Oncology | September 28, 2023 | Volume: 9 | Issue: 11 | Pages: 1592

10.1001/jamaoncol.2023.3329 | PMID 37768645 Get It

This JAMA Oncology Patient Page describes the geriatric assessment used by clinicians to evaluate the health of older adults with cancer.
Microglial over-pruning of synapses during development in autism-associated SCN2A-deficient mice and human cerebral organoids
Wu, Jiaxiang , Zhang, Jingliang , Que, Zhefu , Wettschurack, Kyle , Deming, Brody, Cui, Ningren , Zhao, Yuanrui, Halurkar, Manasi , Purba, Mandal, Chen, Ian , Xiao, Tiange , Suzuki, Matthew M., Chen, Fuxue , Wu, Long-Jun , Yang, Yang , Chen, Xiaoling , Acosta, Maria T. , Eaton, Muriel , Suzuki, Matthew, Yuan, Chongli , Xu, Ranjie , Koss, Wendy A. , Du, Dongshu , Wu, Long‐Jun

No container title available | September 28, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-3270664/v1 | PMID 37841865 Get It

Abstract Autism spectrum disorder (ASD) is a major neurodevelopmental disorder affecting 1 in 36 children in the United States. While neurons have been the focus to understand ASD, an altered neuro-immune response in the brain may be closely associated with ASD, and a neuro-immune interaction could play a role in the disease progression. As the resident immune cells of the brain, microglia regulate brain development and homeostasis via core functions including phagocytosis of synapses. While ASD has been traditionally considered a polygenic disorder, recent large-scale human genetic studies have identified SCN2A deficiency as a leading monogenic cause of ASD and intellectual disability. We generated a Scn2a-deficient mouse model, which displays major behavioral and neuronal phenotypes. However, the role of microglia in this disease model is unknown. Here, we reported that Scn2a-deficient mice have impaired learning and memory, accompanied by reduced synaptic transmission and lower spine density in neurons of the hippocampus. Microglia in Scn2a-deficient mice are partially activated, exerting excessive phagocytic pruning of post-synapses related to the complement C3 cascades during selective developmental stages. The ablation of microglia using PLX3397 partially restores synaptic transmission and spine density. To extend our findings from rodents to human cells, we established a microglial-incorporated human cerebral organoid model carrying an SCN2A protein-truncating mutation identified in children with ASD. We found that human microglia display increased elimination of post-synapse in cerebral organoids carrying the SCN2A mutation. Our study establishes a key role of microglia in multi-species autism-associated models of SCN2A deficiency from mouse to human cells.
Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomes
Ghali, Amer El , Alosaimy, Sara , Lucas, Kristen , Tupayachi-Ortiz, Maria G., Vemula, Raaga, Wadle, Carly , Hamad, Yasir , Zeuli, John D. , Fiske, Christina T. , Simonyan, Anahit, Cimino, Christo , Mammadova, Mehriban, Umana, Virginia, Butt, Saira , Molina, Kyle C. , Thomas, Michael A. , Kaip, Emily A, Gore, Tristan, Howard, Catessa, Cabanilla, M. Gabriela , Frens, Jeremy J , Barger, Melissa, Ong, Aaron, Rybak, Michael J. , El Ghali, Amer , Webb, Andrew J, Rybak, Michael J , Morrisette, Taylor , Philley, Julie V. , Mejía-Chew, Carlos , Stevens, Ryan W. , Webb, Andrew , Hasbun, Rodrigo , Bouchard, Jeannette L. , Holger, Dana J. , Cohen, Keira A.

Antimicrobial Agents and Chemotherapy | September 28, 2023 | Volume: 67 | Issue: 10 | Pages: No page available

10.1128/aac.00824-23 | PMID 37768312 Get It

ABSTRACT Infections due to nontuberculous mycobacteria (NTM) continue to increase in prevalence, leading to problematic clinical outcomes. Omadacycline (OMC) is an aminomethylcycline antibiotic with FDA orphan drug and fast-track designations for pulmonary NTM infections, including Mycobacteroides abscessus (MAB). This multicenter retrospective study across 16 U.S. medical institutions from January 2020 to March 2023 examined the long-term clinical success, safety, and tolerability of OMC for NTM infections. The cohort included patients aged ≥18 yr, who were clinically evaluable, and` had been treated with OMC for ≥3 mo without a previous diagnosis of cystic fibrosis. The primary outcome was 3 mo clinical success, with secondary outcomes including clinical improvement and mortality at 6- and 12 mo, persistence or reemergence of infection, adverse effects, and reasons for OMC utilization. Seventy-five patients were included in this analysis. Most patients were female (48/75, 64.0%) or Caucasian (58/75, 77.3%), with a median (IQR) age of 59 yr (49–67). Most had NTM pulmonary disease (33/75, 44.0%), skin and soft tissue disease (19/75, 25.3%), or osteomyelitis (10/75, 13.3%), and Mycobacterium abscessus (60/75, 80%) was the most commonly isolated NTM pathogen. The median (IQR) treatment duration was 6 mo ( 4 – 14 ), and the most commonly co-administered antibiotic was azithromycin (33/70, 47.1%). Three-month clinical success was observed in 80.0% (60/75) of patients, and AEs attributable to OMC occurred in 32.0% (24/75) of patients, leading to drug discontinuation in 9.3% (7/75).
The First Face Transplant: The Face of Isabelle Dinoire
Boppana, Sri Harsha , Sriram, Shreya, Swathi, Godugu, Kutikuppala, L. V. Simhachalam , Ponnaganti, Sai Venkata Kalyani, Kuchana, Sai Kiran , Kutikuppala, L V Simhachalam

Indian Journal of Transplantation | September 28, 2023 | Volume: 17 | Issue: 3 | Pages: 380-380

10.4103/ijot.ijot_62_22 Get It